Atropos Health Raises $33M to Improve Value-Based Care Through Real-World Evidence
Atropos Health raises $33M on the heels of the adoption of its Generative AI platform (GENEVA OSTM) by healthcare institutions,
Stay updated with breaking news from Brigham Hyde. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Atropos Health raises $33M on the heels of the adoption of its Generative AI platform (GENEVA OSTM) by healthcare institutions,
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.
Atropos Health partners with Google Cloud to rapidly generate insights from healthcare data using natural language AI, improving clinical decision making and advancing their mission to democratize access to real-world evidence.
Health system VC arms appear to have a lot more to offer to startups than traditional VC funds. Startup founders say that the tech pilots they launch with their health system partners end up being more effective because they are more incentive-aligned. For health systems, investing in a startup allows them to have a hand in shaping the tools they will eventually deploy across their enterprises to solve issues like burnout, payment delays and excessive hospital readmissions.
Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.